BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 34023234)

  • 1. Immunological map in COVID-19.
    Li CH; Chiou HC; Lin MH; Kuo CH; Lin YC; Lin YC; Hung CH; Kuo CH
    J Microbiol Immunol Infect; 2021 Aug; 54(4):547-556. PubMed ID: 34023234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
    Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
    Front Immunol; 2021; 12():629193. PubMed ID: 33732251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
    Zhang YY; Li BR; Ning BT
    Front Immunol; 2020; 11():2033. PubMed ID: 32922406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us.
    Kumar V
    Int Rev Immunol; 2021; 40(1-2):5-53. PubMed ID: 32744465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
    Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
    FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
    Yao Z; Zheng Z; Wu K; Junhua Z
    Aging (Albany NY); 2020 May; 12(9):7639-7651. PubMed ID: 32364527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development.
    Ansariniya H; Seifati SM; Zaker E; Zare F
    Biomed Res Int; 2021; 2021():8870425. PubMed ID: 33564683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double edged-sword - The Complement System during SARS-CoV-2 infection.
    Santiesteban-Lores LE; Amamura TA; da Silva TF; Midon LM; Carneiro MC; Isaac L; Bavia L
    Life Sci; 2021 May; 272():119245. PubMed ID: 33609539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.
    İnandıklıoğlu N; Akkoc T
    Adv Exp Med Biol; 2020; 1288():5-12. PubMed ID: 32514817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell-mediated immune response to respiratory coronaviruses.
    Channappanavar R; Zhao J; Perlman S
    Immunol Res; 2014 Aug; 59(1-3):118-28. PubMed ID: 24845462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pathology, molecular pathogenicity, immunological features, and genetic characterization of three highly pathogenic human coronaviruses (MERS-CoV, SARS-CoV, and SARS-CoV-2).
    Rabaan AA; Mutair AA; Alawi ZA; Alhumaid S; Mohaini MA; Aldali J; Tirupathi R; Sule AA; Koritala T; Adhikari R; Bilal M; Dhawan M; Mohapatra RK; Tiwari R; Sami SA; Mitra S; Pandey MK; Harapan H; Emran TB; Dhama K
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7162-7184. PubMed ID: 34859882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs.
    Park A; Harris LK
    Front Immunol; 2021; 12():694355. PubMed ID: 34367154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus vaccine development: from SARS and MERS to COVID-19.
    Li YD; Chi WY; Su JH; Ferrall L; Hung CF; Wu TC
    J Biomed Sci; 2020 Dec; 27(1):104. PubMed ID: 33341119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of COVID-19 on Pregnancy.
    Wang CL; Liu YY; Wu CH; Wang CY; Wang CH; Long CY
    Int J Med Sci; 2021; 18(3):763-767. PubMed ID: 33437211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.
    Liu WJ; Zhao M; Liu K; Xu K; Wong G; Tan W; Gao GF
    Antiviral Res; 2017 Jan; 137():82-92. PubMed ID: 27840203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D.
    Zheng J; Meyerholz D; Wong LR; Gelb M; Murakami M; Perlman S
    J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics.
    Abbasifard M; Khorramdelazad H
    Life Sci; 2020 Sep; 257():118097. PubMed ID: 32679148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2).
    Sessa F; Salerno M; Pomara C
    Medicina (Kaunas); 2021 Mar; 57(4):. PubMed ID: 33806100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.